Search Results

There are 3830 results for: content related to: Correlates of PDE5i Use among Subjects with Erectile Dysfunction in Two Population-Based Surveys

  1. Profiling Characteristics of Men Who Use Phosphodiesterase Type 5 Inhibitors Based on Obtaining Patterns: Data from the Nationwide Japanese Population

    The Journal of Sexual Medicine

    Volume 9, Issue 6, June 2012, Pages: 1649–1658, Masaki Kimura, Satoru Shimura, Hideyuki Kobayashi, Toshihiro Tai, Yutaka Chikano, Shiro Baba, Munehide Kano and Koichi Nagao

    Article first published online : 18 APR 2012, DOI: 10.1111/j.1743-6109.2012.02728.x

  2. Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME)

    The Journal of Sexual Medicine

    Volume 6, Issue 7, July 2009, Pages: 1794–1808, Alan W. Shindel

    Article first published online : 24 JUN 2009, DOI: 10.1111/j.1743-6109.2009.01347.x

  3. Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)

    The Journal of Sexual Medicine

    Volume 6, Issue 9, September 2009, Pages: 2352–2364, Alan W. Shindel

    Article first published online : 26 AUG 2009, DOI: 10.1111/j.1743-6109.2009.01447.x

  4. Recreational Use of Phosphodiesterase Type 5 Inhibitors by Healthy Young Men

    The Journal of Sexual Medicine

    Volume 7, Issue 11, November 2010, Pages: 3736–3742, Amado Bechara, Adolfo Casabé, Walter De Bonis, Adrián Helien and María Victoria Bertolino

    Article first published online : 16 AUG 2010, DOI: 10.1111/j.1743-6109.2010.01965.x

  5. The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation

    The Journal of Sexual Medicine

    Volume 8, Issue 8, August 2011, Pages: 2135–2143, Emmanuele A. Jannini, Chris McMahon, Juza Chen, Antonio Aversa and Michael Perelman

    Article first published online : 26 JUL 2011, DOI: 10.1111/j.1743-6109.2011.02401.x

  6. Combination of Vacuum Erection Device and PDE5 Inhibitors as Salvage Therapy in PDE5 Inhibitor Nonresponders with Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 6, Issue 9, September 2009, Pages: 2561–2567, Onder Canguven, James Bailen, William Fredriksson, David Bock and Arthur L. Burnett

    Article first published online : 16 JUL 2009, DOI: 10.1111/j.1743-6109.2009.01364.x

  7. ORIGINAL RESEARCH–ED PHARMACOTHERAPY: Do Phosphodiesterase Type 5 Inhibitors Protect Against Condom-Associated Erection Loss and Condom Slippage?

    The Journal of Sexual Medicine

    Volume 6, Issue 5, May 2009, Pages: 1451–1456, Stephanie A. Sanders, Robin R. Milhausen, Richard A. Crosby, Cynthia A. Graham and William L. Yarber

    Article first published online : 27 APR 2009, DOI: 10.1111/j.1743-6109.2009.01267.x

  8. Case Study: Erectile Dysfunction Following Spinal Cord Injury (CME)

    The Journal of Sexual Medicine

    Volume 7, Issue 12, December 2010, Pages: 3808–3814, Stacy Elliott

    Article first published online : 1 DEC 2010, DOI: 10.1111/j.1743-6109.2010.02105.x

  9. PROCEEDINGS OF THE WORLD MEETING ON SEXUAL MEDICINE, CHICAGO, USA, AUGUST 26–30 2012

    The Journal of Sexual Medicine

    Volume 9, Issue s4, August 2012, Pages: 183–298,

    Article first published online : 2 AUG 2012, DOI: 10.1111/j.1743-6109.2012.02863.x

  10. Phosphodiesterase Type 5 Inhibitors Facilitate Noncontact Erections in Male Rats: Site of Action in the Brain and Mechanism of Action

    The Journal of Sexual Medicine

    Volume 6, Issue 10, October 2009, Pages: 2680–2689, Fabrizio Sanna, Salvatora Succu, Antonio Boi, Maria Rosaria Melis and Antonio Argiolas

    Article first published online : 12 AUG 2009, DOI: 10.1111/j.1743-6109.2009.01410.x

  11. The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication

    The Journal of Sexual Medicine

    Volume 7, Issue 9, September 2010, Pages: 3153–3160, Antonio Martín Morales, José Ibáñez, Manuel Machuca, Emilio Pol-Yanguas, Gabriel Schnetzler and Virginia Pascual Renedo

    Article first published online : 25 JUN 2010, DOI: 10.1111/j.1743-6109.2010.01918.x

  12. Failure of PDE5 Inhibitor Use: A Case of Nonresponder? (CME)

    The Journal of Sexual Medicine

    Volume 7, Issue 4pt1, April 2010, Pages: 1321–1323, Eric Chung

    Article first published online : 7 APR 2010, DOI: 10.1111/j.1743-6109.2010.01772.x

  13. ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors

    The Journal of Sexual Medicine

    Volume 7, Issue 3, March 2010, Pages: 1237–1246, Gabriel Schnetzler, Ian Banks, Mike Kirby, Kelly H. Zou and Tara Symonds

    Article first published online : 2 FEB 2010, DOI: 10.1111/j.1743-6109.2009.01674.x

  14. You have free access to this content
    Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy

    BJU International

    Volume 110, Issue 11c, December 2012, Pages: E931–E938, Masaki Kimura, Jorge R. Caso, Lionel L. Bañez, Bridget F. Koontz, Leah Gerber, Cagri Senocak, Craig F. Donatucci, Zeljko Vujaskovic, Judd W. Moul and Thomas J. Polascik

    Article first published online : 23 APR 2012, DOI: 10.1111/j.1464-410X.2012.11168.x

  15. REVIEW: Utilization of Pharmacotherapy for Erectile Dysfunction Following Treatment for Prostate Cancer

    The Journal of Sexual Medicine

    Volume 7, Issue 3, March 2010, Pages: 1062–1073, Michaella M. Prasad, Sandip M. Prasad, Nathanael D. Hevelone, Xiangmei Gu, Aaron C. Weinberg, Stuart R. Lipsitz, Ganesh S. Palapattu and Jim C. Hu

    Article first published online : 6 JAN 2010, DOI: 10.1111/j.1743-6109.2009.01644.x

  16. Erectile Function Rehabilitation in the Radical Prostatectomy Patient

    The Journal of Sexual Medicine

    Volume 7, Issue 4pt2, April 2010, Pages: 1687–1698, John P. Mulhall, Anthony J. Bella, Alberto Briganti, Andrew McCullough and Gerald Brock

    Article first published online : 7 APR 2010, DOI: 10.1111/j.1743-6109.2010.01804.x

  17. The Natural Progression and Regression of Erectile Dysfunction: Follow-Up Results from the MMAS and MALES Studies

    The Journal of Sexual Medicine

    Volume 8, Issue 7, July 2011, Pages: 1917–1924, Thomas G. Travison, Michael S. Sand, Raymond C. Rosen, Ridwan Shabsigh, Ian Eardley and John B. McKinlay

    Article first published online : 13 MAY 2011, DOI: 10.1111/j.1743-6109.2011.02294.x

  18. You have full text access to this OnlineOpen article
    Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: findings from a Cochrane systematic review

    BJU International

    Volume 102, Issue 4, August 2008, Pages: 426–431, Bridget Candy, Louise Jones, Rachael Williams, Adrian Tookman and Michael King

    Article first published online : 11 APR 2008, DOI: 10.1111/j.1464-410X.2008.07668.x

  19. Interventions for treating sexual dysfunction in patients with chronic kidney disease

    Intervention Review

    The Cochrane Library

    Mariacristina Vecchio, Sankar D Navaneethan, David W Johnson, Giuseppe Lucisano, Giusi Graziano, Valeria Saglimbene, Marinella Ruospo, Marialuisa Querques, Emmanuele A Jannini and Giovanni FM Strippoli

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD007747.pub2

  20. You have free access to this content
    Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study

    International Journal of Clinical Practice

    Volume 65, Issue 7, July 2011, Pages: 797–806, M. G. Kirby, G. Schnetzler, K.H. Zou and T. Symonds

    Article first published online : 16 JUN 2011, DOI: 10.1111/j.1742-1241.2011.02693.x